Granulocyte colony-stimulating factor (G-CSF) patterns of use in cancer patients receiving myelosuppressive chemotherapy

Comparative Effectiveness of Filgrastim, Pegfilgrastim, and Sargramostim as Prophylaxis Against Hospitalization for Neutropenic Complications in Patients With Cancer Receiving Chemotherapy

(2011) Derek Weycker et al.   AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS

Effect of primary prophylactic G-CSF use on systemic therapy administration for elderly breast cancer patients

(2011) Suja S. Rajan et al.   BREAST CANCER RESEARCH AND TREATMENT

Use of Colony-Stimulating Factors With Chemotherapy: Opportunities for Cost Savings and Improved Outcomes

(2011) A. L. Potosky et al.   JNCI-Journal of the National Cancer Institute

Cost-Effectiveness of White Blood Cell Growth Factor Use among a Large Nationwide Cohort of Elderly Non-Hodgkin's Lymphoma Patients Treated with Chemotherapy

(2011) Stephen K. Gruschkus et al.   VALUE IN HEALTH

Risk of mortality in patients with cancer who experience febrile neutropenia

(2010) Gary H. Lyman et al.   CANCER

Predicting individual risk of neutropenic complications in patients receiving cancer chemotherapy

(2010) Gary H. Lyman et al.   CANCER

Comparative effectiveness of colony-stimulating factors for febrile neutropenia: a retrospective study

(2010) Hiangkiat Tan et al.   CURRENT MEDICAL RESEARCH AND OPINION

2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours

(2010) M.S. Aapro et al.   EUROPEAN JOURNAL OF CANCER

Comparative Effectiveness of White Blood Cell Growth Factors on Neutropenia, Infection, and Survival in Older People with Non-Hodgkin's Lymphoma Treated with Chemotherapy

(2010) Stephen K. Gruschkus et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

Comparison of hospitalization risk and associated costs among patients receiving sargramostim, filgrastim, and pegfilgrastim for chemotherapy-Induced neutropenia

(2009) Mark L. Heaney et al.   CANCER